Literature DB >> 11177448

The old problem of adherence: research on treatment adherence and its relevance for HIV/AIDS.

M T Wright1.   

Abstract

The international published research on patient adherence was selectively reviewed with the goal of determining its relevance for the treatment of HIV/AIDS. Results show that not adhering to treatment regimes is so widespread that no combination of sociodemographic variables is reliably predictive of patients' not following doctors' orders. Achieving 100% adherence for any treatment or patient group does not appear to be realistic. Characteristics of the patient's situation, of the given therapy, and of the disease itself affect adherence. In addition, the patient-doctor relationship and the context of the treatment are important. Often overlooked are the existential dimensions of meaning, self-determination and quality of life which are particularly important for the chronically ill. Treatment needs to be negotiated individually with each patient on the basis of an open therapeutic relationship and with the help of multidimensional interventions. Lessons from the discourse on safer sex can steer adherence research and practice away from a behavioural and reductionist approach toward the context and meaning of treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11177448     DOI: 10.1080/09540120020014237

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  5 in total

Review 1.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

2.  Patient and provider assessments of adherence and the sources of disparities: evidence from diabetes care.

Authors:  Karen E Lutfey; Jonathan D Ketcham
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

3.  Multiple-dose pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered over 21 days with lopinavir-ritonavir in human immunodeficiency virus type 1-infected subjects.

Authors:  Philippe Colucci; John C Pottage; Heather Robison; Jacques Turgeon; Dirk Schürmann; I M Hoepelman; Murray P Ducharme
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

4.  Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia.

Authors:  Alemayehu Amberbir; Kifle Woldemichael; Sofonias Getachew; Belaineh Girma; Kebede Deribe
Journal:  BMC Public Health       Date:  2008-07-30       Impact factor: 3.295

5.  Factors related to poor adherence in Latvian asthma patients.

Authors:  Dins Smits; Girts Brigis; Jana Pavare; Inga Urtane; Sandis Kovalovs; Noël Christopher Barengo
Journal:  Allergy Asthma Clin Immunol       Date:  2020-03-04       Impact factor: 3.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.